Results 171 to 180 of about 3,923 (195)
Some of the next articles are maybe not open access.

Meropenem/vaborbactam cost effective in Italy

PharmacoEconomics & Outcomes News, 2021
openaire   +1 more source

Early Experience With Meropenem-Vaborbactam for Treatment of Carbapenem-Resistant Enterobacteriaceae Infections

Clinical Infectious Diseases, 2020
Liang Chen   +2 more
exaly  

Delafloxacin meglumine, Meropenem trihydrate/vaborbactam, Secnidazole, and Benznidazole

Journal of the American Pharmacists Association, 2018
Daniel A, Hussar, Molly A, Walter
openaire   +2 more sources

Vaborbactam. Beta-Lactamase inhibitor, Antibacterial agent

Drugs of the Future, 2016
null Thakare, R.   +2 more
openaire   +1 more source

In Vitro Activity of Meropenem-Vaborbactam Against Clinical Isolates of KPC-Positive Enterobacteriaceae.

Antimicrobial Agents and Chemotherapy, 2018
Olga Lomovskaya   +2 more
exaly  

Home - About - Disclaimer - Privacy